List of Studies ( Metabolite:SM 18:0;O2/16:0)
Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
---|---|---|---|---|---|---|---|
ST002150 | AN003520 | Sphingomyelin depletion inhibits CXCR4 dynamics and CXCL12-mediated directed cell migration in human T cells | HEK cells | Human | Universidad CEU San Pablo | AREA | |
ST002911 | AN004780 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Lung | Mouse | Tuberculosis | Universidad CEU San Pablo | AREA |
ST002911 | AN004781 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Lung | Mouse | Tuberculosis | Universidad CEU San Pablo | AREA |
ST001819 | AN002952 | EC and PVC from 14-15 month-old APOE3/3, APOE3/4 and APOE4/4 mice | Brain | Mouse | Alzheimers disease | Columbia University | area under the curve |
ST001639 | AN002682 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | AU |
ST001942 | AN003184 | Lipidomics of esophageal adenocarcinoma | Esophagus | Human | Cancer | QIMR Berghofer Medical Research Institute | counts |
ST001336 | AN002226 | Effect of high-fat diet and bile acid treatment on serum and tissue lipidomes in mice | Blood | Mouse | QIMR Berghofer Medical Research Institute | Counts | |
ST002569 | AN004233 | Lipidomic analysis in very-long chain acyl-CoA dehydrogenase null mice | Heart | Mouse | VLCAD deficiency | Montreal Heart Institute | Counts |
ST002747 | AN004457 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | counts, height | |
ST002747 | AN004457 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | counts, height | |
ST001403 | AN002345 | Ontogeny related changes in the pediatric liver metabolome (part-II) | Liver | Human | Moffitt Cancer Center | estimated abundances | |
ST002555 | AN004207 | Ethnicity-Specific Differences in Ovarian Cancer Metabolic Signatures | Cultured cells | Human | Cancer | University of Oklahoma Health Sciences Center | Fold change over standard |
ST001795 | AN002915 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) | Mesenteric lymph | Mouse | Obesity | Monash Institute of Pharmaceutical Sciences | height |
ST001796 | AN002917 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mesenteric lymph | Mus musculus | Diabetes | Monash Institute of Pharmaceutical Sciences | height |
ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham Women's Hospital | intensity |
ST002149 | AN003519 | In vivo commensal control of Clostridioides difficile virulence | Cecum | Mouse | Brigham and Women’s Hospital | Intensity | |
ST001775 | AN002882 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Blood | Mouse | Malaria | Stanford University | ion counts |
ST001710 | AN002785 | Metabolic signatures of NAFLD - Lipidomics data (part 1 of 3) | Blood | Human | Fatty liver disease | Örebro University | log2-transformed autoscaled values |
ST002829 | AN004620 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Blood | Human | COVID-19 | National Institutes of Health | log transformed data |
ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | Metabolon original scale |
ST001686 | AN002753 | Exposure to per- and polyfluoroalkyl substances associates with altered lipid profile of breast milk (Part 3) | Blood | Human | Environmental exposure | University of Turku | ng/ml |
ST001689 | AN002759 | Exposure to per- and polyfluoroalkyl substances associates with altered lipid profile of breast milk (Part 1) | Breast milk | Human | Environmental exposure | University of Turku | ng/ml |
ST000916 | AN001495 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | Blood | Human | Fatty liver disease | LIPID MAPS | nM |
ST000917 | AN001501 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | Urine | Human | Fatty liver disease | LIPID MAPS | nM |
ST001286 | AN002136 | Lipid composition of isolated lipid droplets from the functional bovine corpus luteum | Ovaries | Cow | University of Nebraska Medical Center | nM | |
ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Blood | Mouse | - | University of Kansas | nmol per mg tissue wt |
ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Brain | Mouse | - | University of Kansas | nmol per mg tissue wt |
ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Spinal cord | Mouse | - | University of Kansas | nmol per mg tissue wt |
ST002322 | AN003789 | Metabolomics study comparing SCAP KO and WT B cells | Cultured cells | Mouse | Indiana University School of Medicine | Normalized AUC | |
ST002498 | AN004655 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | peak area |
ST000310 | AN000490 | TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) | Blood | Mouse | Lupus | University of Florida | Peak area |
ST000612 | AN000937 | Sphingolipid Analysis of Human Aqueous Humor in Glaucomatous and Control eyes | Eye tissue | Human | Eye disease | University of Miami | Peak area |
ST000613 | AN000938 | Human TM Sphingolipid Analysis (part II) | Eye tissue | Human | Eye disease | University of Miami | Peak area |
ST000620 | AN000952 | Sphingolipid Analysis of hyper and normotensive DBA2J mice aqueous humor and trabecular meshwork | Mouse | Eye disease | University of Miami | Peak area | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
ST001157 | AN001915 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Blood | Mouse | Johns Hopkins University School of Medicine | Peak area | |
ST001158 | AN001916 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Feces | Mouse | Johns Hopkins University School of Medicine | Peak area | |
ST001212 | AN002044 | Fish-oil supplementation in pregnancy, child metabolomics and asthma risk | Blood | Human | Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen | Peak area | |
ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | Peak area |
ST001935 | AN003147 | Metabolomic profiling of spontaneous macaque model for diabetes mellitus | Blood | Macaque monkey | Diabetes | Xiamen University | Peak area |
ST001935 | AN003147 | Metabolomic profiling of spontaneous macaque model for diabetes mellitus | Liver | Macaque monkey | Diabetes | Xiamen University | Peak area |
ST002505 | AN004127 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | Peak area |
ST002754 | AN004469 | Metabolomics analysis of maternal obesity model | Blood | Mouse | Fatty liver disease | University of Bonn | Peak Area |
ST002909 | AN004776 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Blood | Human | Melioidosis | University of Washington | Peak Area |
ST000362 | AN000594 | Associations between 69 Sphingolipids and Emphysema, Chronic Bronchitis, Exacerbations, and FEV1/FVC | Blood | Human | COPD | National Jewish Health, Colorado | Peak area ratio |
ST000310 | AN000492 | TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) | Blood | Mouse | Lupus | University of Florida | Peak height |
ST001275 | AN002116 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | Peak height |
ST001323 | AN002199 | Effect of high-fat diet on serum lipidome in mice | Blood | Mouse | QIMR Berghofer Medical Research Institute | Peak intensity | |
ST001676 | AN002734 | Lipidomic analysis of CD4+ T-cell subsets (Th1,Th2,Th17 and iTreg cells) (part I) | T-cells | Human | University of Turku | Peak intensity | |
ST000451 | AN000707 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data | Muscle | Mouse | University of North Carolina | Peak values (scaled) | |
ST000452 | AN000708 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data | Blood | Mouse | University of North Carolina | Peak values (scaled) | |
ST001289 | AN002142 | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | Macrophages | Mouse | LIPID MAPS | pmol/1E6 cells | |
ST001827 | AN002963 | The pregnancy metabolome from a multi-ethnic pregnancy cohort | Blood | Human | Icahn School of Medicine at Mount Sinai | pmoles/l | |
ST000915 | AN001489 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | pmol/mg |
ST001288 | AN002141 | Subcellular organelle lipidomics in TLR-4-activated macrophages | Macrophages | Mouse | LIPID MAPS | pmol/mg protein | |
ST001907 | AN003104 | Training-induced bioenergetic improvement in human skeletal muscle is associated with non-stoichiometric changes in the mitochondrial proteome without reorganisation of respiratory chain content | Muscle | Human | Baker Heart and Diabetes Institute | pmol per mg | |
ST002403 | AN003917 | Deep multi-omic profiling reveals extensive mitochondrial remodeling driven by glycemia in early diabetic kidney disease (Mitochondria) | Mitochondria | Rat | Kidney disease | Baker Heart and Diabetes Institute | pmol per mg |
ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Blood | Mouse | Obesity | Baker Heart and Diabetes Institute | pmol per mg (tissues) pmol per ml (plasma) |
ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Epididymal fat | Mouse | Obesity | Baker Heart and Diabetes Institute | pmol per mg (tissues) pmol per ml (plasma) |
ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Liver | Mouse | Obesity | Baker Heart and Diabetes Institute | pmol per mg (tissues) pmol per ml (plasma) |
ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Muscle | Mouse | Obesity | Baker Heart and Diabetes Institute | pmol per mg (tissues) pmol per ml (plasma) |
ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Ventricles | Mouse | Obesity | Baker Heart and Diabetes Institute | pmol per mg (tissues) pmol per ml (plasma) |
ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | pmol/ug DNA | |
ST001019 | AN001667 | Lipidomic profiling of heart and plasma of mice following swim training versus pressure overload | Blood | Mouse | Baker Heart and Diabetes Institute | pmol/umol PC | |
ST001019 | AN001667 | Lipidomic profiling of heart and plasma of mice following swim training versus pressure overload | Heart | Mouse | Baker Heart and Diabetes Institute | pmol/umol PC | |
ST001405 | AN002347 | MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models | Cultured cells | Human | The Ohio State University | ppm | |
ST001983 | AN003234 | Metabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell Lines | Ovarian cancer cells | Human | Cancer | University of Oklahoma Health Sciences Center | ratio |
ST001835 | AN002977 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Blood | Human | Idaho Veterans Research and Education Foundation | raw area count | |
ST000899 | AN001463 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Blood | Human | Inflammatory bowel disease | Vanderbilt University Medical Center | raw area counts |
ST001749 | AN002849 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin - Madison | Raw area counts |
ST002818 | AN004587 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002819 | AN004591 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002820 | AN004595 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | raw area counts rescaled to set the median equal to 1 | |
ST002090 | AN003414 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 2) | Feces | Mouse | Irritable bowel syndrome | Mayo Clinic | raw intensity |
ST000047 | AN000082 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
ST001251 | AN002077 | The effects of a training program encompassing cold exposure, breathing exercises, and meditation on plasma metabomics during experimental human endotoxemia | Blood | Human | Endotoxemia | Radboud University Medical Centre Nijmegen | Relative Abundance |
ST001404 | AN002346 | Ontogeny related changes in the pediatric liver metabolome (part-III) | Liver | Human | Moffitt Cancer Center | Relative Abundance | |
ST001073 | AN001755 | Lipid profiling of Wnt3a-induced optic nerve regeneration | Eye tissue | Mouse | Eye disease | Bascom Palmer Eye Institute, University of Miami | relative abundance (main area) |
ST002088 | AN003407 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | relativeMedian |
ST002089 | AN003411 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | relativeMedian |
ST001869 | AN003031 | WNK463 Inhibition on Right Ventricular metabolomics | Heart | Rat | Hypertension | University of Minnesota | relative value |
ST001870 | AN003032 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Heart | Rat | University of Minnesota | relative value | |
ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
ST002018 | AN003288 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Feces | Human | Vanderbilt University Medical Center | scaled imputed | |
ST002019 | AN003289 | TIPs Metabolomics (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
ST000930 | AN001524 | Define alterations in the gut metabolome of mice infected with C. difficile | Intestine | Mouse | North Carolina State University | scaled intensity | |
ST001919 | AN003118 | Exposure to environmental contaminants is associated with alterations in hepatic lipid metabolism in non-alcoholic fatty liver disease | Liver | Mouse | Fatty liver disease | Örebro University | Summarised value |
ST001253 | AN002080 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Blood | Mouse | Diabetes | Indiana University School of Medicine | VolNormImp Area counts |